Dr. Said has deep international strategic, operational and research expertise working across academia and the healthcare industry. Previously, she was SVP and Global Head of Oncology Policy and Market Access at Novartis and member of the Oncology Business Unit Executive Committee. In this role, she drove the overall worldwide strategy and operations for the oncology business on pricing, market access, stakeholder engagement and other areas related to patients’ access to Novartis oncology products including the creation of payer-relevant clinical, real world and economic evidence. Earlier at Sanofi, she was VP and Head of Global R&D Strategy, Science Policy & External Innovation, a member of the Sanofi Global LT, the Global R&D Executive Committee and chaired the Working Group that reviewed all external opportunities within the scope of Global R&D. She spent over seven years at The Boston Consulting Group where she was a core member of the Healthcare and Strategy practice areas.
Dr. Said holds undergraduate degrees in Biology as well as Electrical Engineering & Computer Science (EECS); Masters degrees in Toxicology and Engineering in Electrical Engineering and Computer Science; Doctorates in Electrical Engineering, Computer Science and Systems Biology, all from the Massachusetts Institute of Technology.